A Study of DSP-7888 Dosing Emulsion in Combination With Immune Checkpoint Inhibitors in Adult Patients With Advanced Solid Tumors

Clinical trial NCT03311334 · TERMINATED

Trial details

NCT number: NCT03311334
Sponsor: Sumitomo Pharma America, Inc.
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Renal Cell Carcinoma (RCC)Urothelial Carcinoma Primary Peritoneal Cancer Platinum-resistant Ovarian Cancer (PROC)Serous Epithelial Ovarian Cancer Fallopian Tube Cancer

Start date: 2017-12-14
Primary completion: 2022-10-19
Enrollment: 47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.